Commodore Capital’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.4M | Sell |
427,866
-497,134
| -54% | -$7.43M | 0.45% | 31 |
|
|
2025
Q1 | $10.8M | Buy |
925,000
+125,000
| +16% | +$1.46M | 0.8% | 26 |
|
|
2024
Q4 | $18.3M | Buy |
800,000
+600,000
| +300% | +$13.7M | 1.34% | 20 |
|
|
2024
Q3 | $8.39M | Hold |
200,000
| – | – | 0.52% | 31 |
|
|
2024
Q2 | $7.28M | Hold |
200,000
| – | – | 0.5% | 30 |
|
|
2024
Q1 | $10.2M | Buy |
+200,000
| New | +$10.2M | 0.68% | 30 |
|